Real-time enrollment status for this hidradenitis suppurativa (hs) clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 11:16 PM UTC
| NCT Number | NCT07766005 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa (HS) |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Spyre Therapeutics, Inc. |
| Last Updated on CT.gov | October 19, 2026 (23 hours ago) |
As of October 19, 2026: Clinical trial NCT07766005 is currently recruiting participants. This phase2 study for hidradenitis suppurativa (hs) is actively seeking new participants at 26 locations across the United States. The study is sponsored by Spyre Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07766005 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07766005 was last updated 23 hours ago (October 19, 2026). HelloStudys verifies this status automatically.